US Stock MarketDetailed Quotes

Bolt Biotherapeutics (BOLT)

Watchlist
  • 4.830
  • +0.060+1.26%
Close Apr 24 16:00 ET
  • 4.830
  • 0.0000.00%
Post 20:01 ET
9.28MMarket Cap-0.27P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Bolt Biotherapeutics (BOLT) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2025
(Q4)Dec 31, 2025
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
34.98%-39.85M
50.41%-7.16M
30.32%-9.73M
40.55%-9.6M
20.21%-13.37M
11.85%-61.29M
-1.16%-14.43M
16.62%-13.97M
-6.82%-16.14M
28.41%-16.75M
Net income from continuing operations
47.12%-33.38M
58.39%-6.63M
52.93%-7.14M
59.61%-8.56M
-2.12%-11.04M
8.79%-63.12M
10.99%-15.94M
6.65%-15.18M
-17.38%-21.2M
36.33%-10.81M
Operating gains losses
-311.43%-288K
--0
--0
--0
---288K
---70K
--0
----
----
----
Depreciation and amortization
-27.51%1.29M
-40.14%255K
-34.09%290K
-24.07%347K
-12.88%399K
-3.94%1.78M
-8.78%426K
-4.76%440K
-0.22%457K
-1.93%458K
Other non cash items
9.97%2.53M
1,071.64%651K
-20.80%636K
-20.81%624K
-20.44%615K
-22.19%2.3M
-108.84%-67K
7.93%803K
7.80%788K
7.51%773K
Change In working capital
-43.54%-12.12M
-93.23%-2.31M
-555.88%-3.79M
-238.78%-2.46M
57.93%-3.55M
14.44%-8.44M
-177.71%-1.2M
78.53%-578K
242.47%1.77M
8.55%-8.44M
-Change in prepaid assets
-97.04%76K
430.67%398K
-121.61%-86K
-103.01%-67K
-30.00%-169K
666.30%2.57M
-95.70%75K
131.34%398K
396.21%2.23M
90.56%-130K
-Change in payables and accrued expense
-11.20%-5.43M
92.70%-197K
-523.87%-1.88M
-191.80%-840K
29.15%-2.51M
-43.07%-4.88M
-327.10%-2.7M
-46.31%444K
-22.65%915K
46.39%-3.54M
-Change in other current liabilities
-45.64%-2.12M
-200.32%-632K
16.81%-594K
22.34%-525K
47.05%-368K
39.15%-1.46M
198.75%630K
-16.10%-714K
-16.55%-676K
-24.55%-695K
-Change in other working capital
0.66%-4.64M
-335.88%-1.88M
-74.08%-1.23M
-48.63%-1.03M
87.64%-503K
-29.59%-4.67M
205.56%797K
56.79%-706K
-29.78%-693K
-496.05%-4.07M
Cash from discontinued investing activities
Operating cash flow
34.98%-39.85M
50.41%-7.16M
30.32%-9.73M
40.55%-9.6M
20.21%-13.37M
11.85%-61.29M
-1.16%-14.43M
16.62%-13.97M
-6.82%-16.14M
28.41%-16.75M
Investing cash flow
Cash flow from continuing investing activities
-23.05%44.3M
-91.22%1.07M
4.35%17.88M
-40.05%10.79M
42.61%14.55M
-18.95%57.58M
-22.63%12.23M
35.39%17.14M
32.57%18M
-64.81%10.2M
Net PPE purchase and sale
732.71%891K
--0
-167.29%-72K
--0
--963K
151.94%107K
--0
164.85%107K
--0
--0
Net investment purchase and sale
-24.46%43.41M
-91.22%1.07M
5.43%17.96M
-40.05%10.79M
33.18%13.59M
-19.33%57.47M
-22.66%12.23M
32.82%17.03M
32.26%18M
-64.81%10.2M
Cash from discontinued investing activities
Investing cash flow
-23.05%44.3M
-91.22%1.07M
4.35%17.88M
-40.05%10.79M
42.61%14.55M
-18.95%57.58M
-22.63%12.23M
35.39%17.14M
32.57%18M
-64.81%10.2M
Financing cash flow
Cash flow from continuing financing activities
-82.41%19K
-82.76%5K
0
-57.31%108K
-72.64%29K
0
Net common stock issuance
-82.41%19K
-82.76%5K
--0
----
----
-57.31%108K
-72.64%29K
--0
----
----
Cash from discontinued financing activities
Financing cash flow
-82.41%19K
-82.76%5K
--0
-82.28%14K
--0
-57.31%108K
-72.64%29K
--0
--79K
--0
Net cash flow
Beginning cash position
-28.67%8.97M
75.22%19.52M
42.66%11.37M
68.51%10.16M
-28.67%8.97M
16.34%12.58M
1.96%11.14M
-46.94%7.97M
-63.25%6.03M
16.34%12.58M
Current changes in cash
224.02%4.47M
-180.18%-6.08M
157.00%8.15M
-37.63%1.21M
118.11%1.19M
-304.13%-3.61M
-231.45%-2.17M
177.54%3.17M
240.07%1.94M
-217.10%-6.55M
End cash Position
49.84%13.44M
49.84%13.44M
75.22%19.52M
42.66%11.37M
68.51%10.16M
-28.67%8.97M
-28.67%8.97M
1.96%11.14M
-46.94%7.97M
-63.25%6.03M
Free cash flow
34.91%-39.92M
50.41%-7.16M
30.01%-9.8M
40.55%-9.6M
20.21%-13.37M
12.05%-61.33M
-1.11%-14.43M
17.19%-14.01M
-6.59%-16.14M
28.42%-16.75M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
(FY)Dec 31, 2025(Q4)Dec 31, 2025(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 34.98%-39.85M50.41%-7.16M30.32%-9.73M40.55%-9.6M20.21%-13.37M11.85%-61.29M-1.16%-14.43M16.62%-13.97M-6.82%-16.14M28.41%-16.75M
Net income from continuing operations 47.12%-33.38M58.39%-6.63M52.93%-7.14M59.61%-8.56M-2.12%-11.04M8.79%-63.12M10.99%-15.94M6.65%-15.18M-17.38%-21.2M36.33%-10.81M
Operating gains losses -311.43%-288K--0--0--0---288K---70K--0------------
Depreciation and amortization -27.51%1.29M-40.14%255K-34.09%290K-24.07%347K-12.88%399K-3.94%1.78M-8.78%426K-4.76%440K-0.22%457K-1.93%458K
Other non cash items 9.97%2.53M1,071.64%651K-20.80%636K-20.81%624K-20.44%615K-22.19%2.3M-108.84%-67K7.93%803K7.80%788K7.51%773K
Change In working capital -43.54%-12.12M-93.23%-2.31M-555.88%-3.79M-238.78%-2.46M57.93%-3.55M14.44%-8.44M-177.71%-1.2M78.53%-578K242.47%1.77M8.55%-8.44M
-Change in prepaid assets -97.04%76K430.67%398K-121.61%-86K-103.01%-67K-30.00%-169K666.30%2.57M-95.70%75K131.34%398K396.21%2.23M90.56%-130K
-Change in payables and accrued expense -11.20%-5.43M92.70%-197K-523.87%-1.88M-191.80%-840K29.15%-2.51M-43.07%-4.88M-327.10%-2.7M-46.31%444K-22.65%915K46.39%-3.54M
-Change in other current liabilities -45.64%-2.12M-200.32%-632K16.81%-594K22.34%-525K47.05%-368K39.15%-1.46M198.75%630K-16.10%-714K-16.55%-676K-24.55%-695K
-Change in other working capital 0.66%-4.64M-335.88%-1.88M-74.08%-1.23M-48.63%-1.03M87.64%-503K-29.59%-4.67M205.56%797K56.79%-706K-29.78%-693K-496.05%-4.07M
Cash from discontinued investing activities
Operating cash flow 34.98%-39.85M50.41%-7.16M30.32%-9.73M40.55%-9.6M20.21%-13.37M11.85%-61.29M-1.16%-14.43M16.62%-13.97M-6.82%-16.14M28.41%-16.75M
Investing cash flow
Cash flow from continuing investing activities -23.05%44.3M-91.22%1.07M4.35%17.88M-40.05%10.79M42.61%14.55M-18.95%57.58M-22.63%12.23M35.39%17.14M32.57%18M-64.81%10.2M
Net PPE purchase and sale 732.71%891K--0-167.29%-72K--0--963K151.94%107K--0164.85%107K--0--0
Net investment purchase and sale -24.46%43.41M-91.22%1.07M5.43%17.96M-40.05%10.79M33.18%13.59M-19.33%57.47M-22.66%12.23M32.82%17.03M32.26%18M-64.81%10.2M
Cash from discontinued investing activities
Investing cash flow -23.05%44.3M-91.22%1.07M4.35%17.88M-40.05%10.79M42.61%14.55M-18.95%57.58M-22.63%12.23M35.39%17.14M32.57%18M-64.81%10.2M
Financing cash flow
Cash flow from continuing financing activities -82.41%19K-82.76%5K0-57.31%108K-72.64%29K0
Net common stock issuance -82.41%19K-82.76%5K--0---------57.31%108K-72.64%29K--0--------
Cash from discontinued financing activities
Financing cash flow -82.41%19K-82.76%5K--0-82.28%14K--0-57.31%108K-72.64%29K--0--79K--0
Net cash flow
Beginning cash position -28.67%8.97M75.22%19.52M42.66%11.37M68.51%10.16M-28.67%8.97M16.34%12.58M1.96%11.14M-46.94%7.97M-63.25%6.03M16.34%12.58M
Current changes in cash 224.02%4.47M-180.18%-6.08M157.00%8.15M-37.63%1.21M118.11%1.19M-304.13%-3.61M-231.45%-2.17M177.54%3.17M240.07%1.94M-217.10%-6.55M
End cash Position 49.84%13.44M49.84%13.44M75.22%19.52M42.66%11.37M68.51%10.16M-28.67%8.97M-28.67%8.97M1.96%11.14M-46.94%7.97M-63.25%6.03M
Free cash flow 34.91%-39.92M50.41%-7.16M30.01%-9.8M40.55%-9.6M20.21%-13.37M12.05%-61.33M-1.11%-14.43M17.19%-14.01M-6.59%-16.14M28.42%-16.75M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes--------
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
According to Lebanese media reports, in the early hours of the 27th local time, Iran conveyed a three-phase negotiation plan to the US throu Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -